Table of Contents
Scholarly Research Exchange
Volume 2008 (2008), Article ID 430531, 3 pages
http://dx.doi.org/10.3814/2008/430531
Case Report

Serum False-Positive Botulism in Guillain-Barré Syndrome

1Department of Neurology, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai Road, 112 Taipei, Taiwan
2Department of Neurology, National Yang-Ming University School of Medicine, 155, Section 2, Linong Street, Taipei 112, Taiwan

Received 9 August 2008; Revised 22 September 2008; Accepted 30 September 2008

Copyright © 2008 Yen-Chi Yeh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Cai, B. R. Singh, and S. Sharma, “Botulism diagnostics: from clinical symptoms to in vitro assays,” Critical Reviews in Microbiology, vol. 33, no. 2, pp. 109–125, 2007. View at Publisher · View at Google Scholar · View at PubMed
  2. K. P. Lin, M. H. Chan, and Z. A. Wu, “Nerve conduction studies in healthy Chinese: correlation with age, sex, height and skin temperature,” Zhonghua Yi Xue Za Zhi, vol. 52, no. 5, pp. 293–297, 1993. View at Google Scholar
  3. S. H. W. Notermans, J. H. J. Wokke, and L. H. van den Berg, “Botulism and Guillain-Barré syndrome,” The Lancet, vol. 340, no. 8814, p. 303, 1992. View at Publisher · View at Google Scholar
  4. V. H. Chang and L. R. Robinson, “Serum positive botulism with neuropathic features,” Archives of Physical Medicine and Rehabilitation, vol. 81, no. 1, pp. 122–126, 2000. View at Publisher · View at Google Scholar
  5. F. G. A. Van der Meché, P. A. Van Doorn, J. Meulstee, and F. G. I. Jennekens, “Diagnostic and classification criteria for the Guillain-Barré syndrome,” European Neurology, vol. 45, no. 3, pp. 133–139, 2001. View at Publisher · View at Google Scholar
  6. S. S. Arnon, R. Schechter, T. V. Inglesby et al., “Botulinum toxin as a biological weapon: medical and public health management,” The Journal of the American Medical Association, vol. 285, no. 8, pp. 1059–1070, 2001. View at Publisher · View at Google Scholar
  7. K. Susuki, H. Takahashi, N. Yuki, H. Ohsawa, K. Hirata, and I. Sakata, “Guillain-Barré syndrome mimicking botulism,” Journal of Neurology, vol. 248, no. 8, pp. 720–721, 2001. View at Publisher · View at Google Scholar
  8. J. Dörr, F. J. Dieste, D. Klaasen van Husen, F. Zipp, and H. P. Vogel, “A case of recurrent Miller Fisher syndrome mimicking botulism,” Neurological Sciences, vol. 27, no. 6, pp. 424–425, 2006. View at Publisher · View at Google Scholar · View at PubMed
  9. M. Cherington, “Clinical spectrum of botulism,” Muscle & Nerve, vol. 21, no. 6, pp. 701–710, 1998. View at Publisher · View at Google Scholar